v3.26.1
UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($)
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Aug. 11, 2025 $ 0 $ 0 $ 0 $ 0
Balance (in Shares) at Aug. 11, 2025 0      
Issuance of ordinary shares to Sponsor [1] $ 383 24,617 0 25,000
Issuance of ordinary shares to Sponsor (in Shares) [1] 3,833,333      
Net income (loss)     (33,511) (33,511)
Balance at Aug. 31, 2025 $ 383 24,617 (33,511) (8,511)
Balance (in Shares) at Aug. 31, 2025 3,833,333      
Net income (loss)     (42,374) (42,374)
Balance at Nov. 30, 2025 $ 383 24,617 (75,885) (50,885)
Balance (in Shares) at Nov. 30, 2025 3,833,333      
Balance at Aug. 31, 2025 $ 383 24,617 (33,511) (8,511)
Balance (in Shares) at Aug. 31, 2025 3,833,333      
Accretion of ordinary share subject to redemption value       (4,773,413)
Net income (loss)       (175)
Balance at Feb. 28, 2026 $ 439 524,817 (146,186) 379,070
Balance (in Shares) at Feb. 28, 2026 4,388,303      
Balance at Nov. 30, 2025 $ 383 24,617 (75,885) (50,885)
Balance (in Shares) at Nov. 30, 2025 3,833,333      
Value allocated to Over-allotment option liability   (127,200)   (127,200)
Sale of private placement shares $ 16 1,549,684   1,549,700
Sale of private placement shares (in Shares) 154,970      
Issuance of representative shares $ 40 3,983,960   3,984,000
Issuance of representative shares (in Shares) 400,000      
Allocated value of transaction costs to ordinary shares   (260,031)   (260,031)
Accretion of ordinary share subject to redemption value   (4,646,213)   (4,646,213)
Remeasurement of carrying value to redemption value     (112,500) (112,500)
Net income (loss)     42,199 42,199
Balance at Feb. 28, 2026 $ 439 $ 524,817 $ (146,186) $ 379,070
Balance (in Shares) at Feb. 28, 2026 4,388,303      
[1] Excludes an aggregate of up to 500,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7).